文献速递新生儿

产前大麻使用与新生儿结局:系统综述与荟萃分析

Prenatal Cannabis Use and Neonatal Outcomes: A Systematic Review and Meta-Analysis.
PubMed 文献 · JAMA Pediatr · 2025-05-05

调整混杂因素后,中等确定性证据显示产前大麻使用与低出生体重(OR 1.75)、早产(OR 1.52)和小于胎龄儿(OR 1.57)风险增加相关,低确定性证据显示与围产期死亡风险增加相关(OR 1.29)。

要点

  • 产前大麻使用与低出生体重、早产和小于胎龄儿风险增加相关,证据确定性为中等。
  • 即使调整烟草共用等混杂因素,上述关联仍然存在。
  • 围产期死亡风险增加关联的证据确定性较低。

核心结论

  • 产前大麻使用与早产、小于胎龄儿和低出生体重的 odds 增加相关,即使调整烟草共用后关联仍存在。
  • 证据确定性从先前综述的低升级为当前荟萃分析的中等。

研究设计与样本

  • 更新版 living 系统综述与荟萃分析,纳入队列或病例对照研究。
  • 采用随机效应荟萃分析合并未调整和调整后的比值比(OR),并使用 GRADE 方法评估证据质量。

主要发现

  • 调整效应量荟萃分析显示,产前大麻使用与低出生体重风险增加相关(20项研究;OR 1.75;95% CI 1.41-2.18;中等确定性)。
  • 产前大麻使用与早产风险增加相关(20项研究;OR 1.52;95% CI 1.26-1.83;中等确定性)。
  • 产前大麻使用与小于胎龄儿风险增加相关(12项研究;OR 1.57;95% CI 1.36-1.81;中等确定性)。
  • 产前大麻使用与围产期死亡风险增加相关(6项研究;OR 1.29;95% CI 1.07-1.55;低确定性)。

关键数值与推荐

  • 主要结局包括早产(<37周妊娠)、小于胎龄儿、低出生体重(<2500 g)和围产期死亡。
  • 纳入研究需比较产前使用与未使用大麻的妊娠,并对烟草产品共用等混杂因素进行调整。
  • 证据确定性评级:低出生体重、早产和小于胎龄儿为中等;围产期死亡为低。

临床怎么用

  • 产前大麻使用与不良新生儿结局的关联可用于患者咨询,帮助告知孕妇相关风险。
  • 研究结果可为未来公共卫生政策提供参考。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Prenatal cannabis use continues to increase, and cannabis remains the most commonly used illegal substance in pregnancy. Accumulating evidence suggests potential adverse effects on fetal and neonatal outcomes following cannabis use in pregnancy. OBJECTIVE: To update a living systematic review and meta-analysis to provide a timely understanding regarding cannabis use in pregnancy and fetal and neonatal outcomes. DATA SOURCES: The previous review was updated by searching bibliographic databases MEDLINE, CINAHL, PsycInfo, Global Health, and Evidence-Based Medicine Reviews Cochrane Database of Systematic Reviews from November 1, 2021, through April 4, 2024. STUDY SELECTION: Cohort or case-control studies comparing pregnancies with and without prenatal cannabis use on prespecified fetal or neonatal outcomes with adjustment for confounders, such as co-use of tobacco products, were included. Two independent reviewers screened studies, with disagreements resolved through discussion. DATA EXTRACTION AND SYNTHESIS: Included studies were extracted by 1 reviewer and confirmed by a second. Risk of bias was assessed with the Newcastle-Ottawa Scale. Random-effects meta-analyses of unadjusted and adjusted odds ratios (ORs) were performed for all primary outcomes. Results were synthesized using the Grading of Recommendations Assessment, Development, and Evaluation approach. MAIN OUTCOMES AND MEASURES: Primary outcomes were preterm birth (PTB; <37 weeks of gestation), small for gestational age (SGA), low birth weight (LBW; <2500 g), and perinatal mortality. RESULTS: For this update, 8 new studies with 1 709 998 participants were added, for a total of 51 studies synthesized (N = 21 146 938). From meta-analyses of adjusted effect sizes, moderate-certainty evidence indicated that cannabis use in pregnancy was associated with increased odds of LBW (20 studies; OR, 1.75; 95% CI, 1.41-2.18), PTB (20 studies; OR, 1.52; 95% CI, 1.26-1.83), and SGA (12 studies; OR, 1.57; 95% CI, 1.36-1.81), and low-certainty evidence indicated that it was associated with greater odds of perinatal mortality (6 studies; OR, 1.29; 95% CI, 1.07-1.55). Previously, the evidence was rated as very low or low certainty. CONCLUSIONS AND RELEVANCE: Cannabis use in pregnancy was associated with greater odds of PTB, SGA, and LBW even after adjusting for co-use of tobacco products, and confidence in these findings increased from low in the prior review to moderate in the current meta-analysis. The findings of this study may help inform patient counseling and future public health policies.

来源:JAMA Pediatr,查看原文。版权归原作者所有。

引用

  1. Lo JO, Ayers CK, Yeddala S, et al. Prenatal Cannabis Use and Neonatal Outcomes: A Systematic Review and Meta-Analysis. JAMA Pediatr. 2025. PMID: 40323610. doi:10.1001/jamapediatrics.2025.0689

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。